Purchase Order 36C25925P0299
Award Date
12/27/24
Potential Completion Date
1/7/25
Potential Value
$50K
Federal Agency
Veterans Integrated Service Network 19
Awardee
Profounda Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Orlando, FL 32824, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $49,950.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, to VA medical centers within the Veterans Integrated Service Network 20 (VISN 20). Profounda Inc. holds a...
The Department of Veterans Affairs' Veterans Health Administration awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business, to provide Miltefosine drug with a potential value of $149,950.00. The order, placed under the VHA's Veterans Integrated Service Network 23, supports the agency's mission to deliver healthcare services to veterans by ensuring access to this specialized pharmaceutical product needed for treatment. Profounda has previously...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $99,900.00, is for the delivery of Miltefosine 50mg tablets, a critical medication used to treat leishmaniasis and other drug-resistant infections. This purchase order is part of a larger $1,127,000 Blanket Purchase Agreement (BPA) held by Profounda Inc. with the VA's...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network (VISN) 20, to Profounda Inc. for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract, valued at $16,650.00, does not have a set-aside designation and is intended to support the VA's mission of providing healthcare services to veterans by ensuring rapid access to...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a $299,700.00 firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business manufacturer of pharmaceutical products, to provide the medication Impavido (miltefosine) to the Puget Sound VA Medical Center. This sole-source procurement is to acquire this specialized drug for treating Disseminated Cutaneous Acanthamboeba, with a performance period from May 1, 2025, to October 30,...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer. The $116,550 contract is for the delivery of Miltefosine, a medication used to treat leishmaniasis and other drug-resistant infections in veterans. The contract has an ultimate completion date of September 30, 2024 and is part of a larger $1,127,000 Blanket Purchase Agreement (BPA)...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer, for the delivery of Emergency Patient Profounda Miltefosine Dose Packs. The $16,650 contract has an April 30, 2024 completion date and supports the VHA's mission to provide healthcare services to veterans by ensuring access to this specialty pharmaceutical product. Profounda has previously received...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $49,950.00 contract is for the delivery of the emergency medication miltefosine (Impavido) to the Minneapolis VA Medical Center. Profounda Inc. has a significant Blanket Purchase Agreement (BPA) with VISN 8 to provide miltefosine on a...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $96,000.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, with a focus on providing emergency pharmaceutical solutions to veterans. Profounda Inc. has a...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $144,000.00 firm fixed-price purchase order is for the delivery of Impavido/Miltefosine, a specialized medication used to treat leishmaniasis and other drug-resistant infections in veterans. Profounda Inc. has received numerous similar purchase orders from various Veterans Integrated...